Bahia Grass Allergy Shots: The Grass That Fooled Gulf Coast Allergists
Bahia grass allergy shots (SCIT) target Paspalum notatum — the Panicoideae grass that dominated Florida pollen counts for decades while being misdiagnosed as melaleuca allergy. Stablein et al. (2002) showed that apparent melaleuca skin-test reactivity in Florida patients was actually bahia cross-reactivity, rewriting the Gulf Coast testing playbook.
About Curex’s SCIT program
Curex’s at-home allergy shots (SCIT) are coming soon and focus on the most common environmental allergens:
- • Pollens — tree, grass, weed & ragweed
- • Pet dander — cat & dog
- • Dust mites
- • Molds — Alternaria & mold mix
Bahia Grassis covered here for general education and may not be part of Curex’s current treatment set. Join the waitlist and our care team will help confirm your options.
Bahia Grass Allergy Immunotherapy: How It Works
Allergy immunotherapy is the only long-term treatment that re-trains the immune system to stop overreacting to bahia grass — rather than just masking symptoms with antihistamines or steroids. By gradually exposing the body to controlled doses of bahia grass allergen, immunotherapy shifts the underlying allergic response and produces relief that often outlasts treatment by 7–10 years.
There are two evidence-based forms of bahia grass immunotherapy used today, both built on the same desensitization principle but delivered very differently.
of sustained relief after a complete immunotherapy course — the only allergy treatment with proven long-term effect after stopping.
Allergy Shots (SCIT)
Weekly injections of bahia grass extract in a clinic, escalating over 3–6 months until a maintenance dose is reached. Continued monthly for 3–5 years. Longest clinical track record for bahia grass allergy.
- Strongest evidence base for severe and polysensitized patients
- Covered by most insurance plans
- Requires 50–100+ in-person clinic visits across the full course
- Or at home with no clinic visits— Curex’s Virtual Shot Room model delivers the same SCIT program with live video supervision by trained Curex clinical staff for the first injection from each new vial or concentration and restarts after gaps or reactions.
Allergy Drops / Tablets (SLIT)
Daily drops or dissolvable tablets containing bahia grass extract, held under the tongue at home. Same desensitization principle, delivered without injections. WHO-recognized as an effective form of allergy immunotherapy since 2001.
- Taken at home — no weekly clinic trips, no needles
- Lower systemic reaction rate than allergy shots
- Curex offers prescription bahia grass immunotherapy drops with allergist oversight
The rest of this page goes deep on allergen-specific immunotherapy with shots — protocol, efficacy data, side effects, and cost. If you’d rather skip the clinic and treat bahia grass allergy with at-home drops, see how Curex sublingual immunotherapy compares below.
What is Bahia Grass?
The biology, taxonomy, and clinical fingerprint of Bahia Grass — the foundation of how SCIT targets it.
Bahia grass (Paspalum notatum) with its characteristic Y-shaped raceme seedhead — the dominant roadside and pasture grass across Florida, releasing pollen April through October at counts routinely exceeding 200 grains/m³.
- Scientific name
- Paspalum notatum
- Family
- Poaceae (Panicoideae)Grass family — warm-season Panicoideae
- Type
- Perennial warm-season grass pollen
- Native to
- South America (Brazil/Argentina); naturalized throughout Florida, Gulf Coast, and Central America
- Allergen proteins
- Pas n 1 (major) — Group 1 beta-expansin, highest sensitization rate in Texas allergy clinics (Schwietz et al., 2000)
- Particle size
- 35–40 μm
- Avoidance difficulty
- Nearly impossible
How Bahia Grass Allergy Presents
Symptoms by body system — useful for distinguishing Bahia Grass sensitivity from overlapping allergies and infections.
Respiratory
- Severe sneezing and rhinorrhea during April–October Florida pollen season
- Nasal congestion that persists through the full summer — often mistaken for perennial allergic rhinitis
- Asthma exacerbations on days with pollen counts above 200 grains/m³ in Tampa and Jacksonville
- Wheezing after outdoor activity in fields or along roadsides where bahia dominates
- Chronic post-nasal drip with nighttime cough throughout the Gulf Coast summer
Ocular
- Intense bilateral eye itching and watering during pollen peaks in May–June
- Conjunctival redness that persists through field or outdoor activity
- Eyelid swelling after prolonged exposure to roadside bahia stands
- Increased light sensitivity during high-count summer days
Dermal
- Contact urticaria after walking through or sitting in bahia-dominant areas
- Eczema exacerbations during May–June peak season
- Mild rash after direct skin contact with the distinctive Y-shaped seedheads
Systemic
- Fatigue and brain fog persisting through Florida's long bahia season
- Sleep disruption from prolonged nighttime nasal congestion
- Reduced outdoor activity tolerance in bahia-heavy landscaped areas
- Quality-of-life impairment across the 6-month Gulf Coast pollen window
For years, Florida allergists saw apparent melaleuca skin test reactivity and concluded patients had melaleuca allergy. The Stablein study changed that — we realized bahia's Pas n 1 was cross-reacting with melaleuca extracts on the skin prick panel. Now when I see a Gulf Coast patient with apparent melaleuca positivity, the first question I ask is: have we actually tested for bahia-grass IgE?
When & Where Bahia Grass Peaks
Allergen intensity by month and by state. Useful for timing SCIT start dates and travel planning.
12-Month Intensity
Peak: May–June across Florida and the Gulf Coast; pollen counts routinely exceed 200 grains/m³ at NAB Tampa and Jacksonville stations· April–October in Florida with year-round background exposure in Miami-Dade and the Florida Keys
US Exposure Map
6 high-intensity statesExposure intensity by state (text version)
- ME:
- Low
- VT:
- Low
- NH:
- Low
- WA:
- Low
- MT:
- Low
- ND:
- Low
- MN:
- Low
- WI:
- Low
- MI:
- Low
- NY:
- Low
- MA:
- Low
- OR:
- Low
- ID:
- Low
- WY:
- Low
- SD:
- Low
- IA:
- Low
- IL:
- Low
- IN:
- Low
- OH:
- Low
- PA:
- Low
- NJ:
- Low
- CT:
- Low
- RI:
- Low
- CA:
- Low
- NV:
- Low
- UT:
- Low
- CO:
- Low
- NE:
- Low
- MO:
- Low
- KY:
- Low
- WV:
- Low
- VA:
- Low
- MD:
- Low
- DE:
- Low
- AZ:
- Low
- NM:
- Low
- KS:
- Low
- AR:
- Moderate
- TN:
- Low
- NC:
- Moderate
- SC:
- Moderate
- OK:
- Moderate
- LA:
- High
- MS:
- High
- AL:
- High
- GA:
- High
- TX:
- High
- FL:
- High
- AK:
- Low
- HI:
- Low
What Bahia Grass Cross-Reacts With
Patients sensitized to one allergen often react to others sharing similar proteins. This map shows the documented molecular overlaps.
Bahia grass (Panicoideae) shares Group 1 beta-expansin allergens across warm-season grasses but cross-reacts only weakly (~38%) with the Pooideae cluster — and its cross-reactivity with melaleuca extracts on skin testing caused a two-decade misdiagnosis pattern in Florida clinics.
Panicoideae subfamily — Sor h 1 shows ~70% IgE inhibition with Pas n 1 (Esch & Bush, 2008)
Panicoideae — Group 1 cross-reactivity inferred from subfamily classification
Chloridoideae — partial Group 1 cross-reactivity; separate vials recommended for optimal SCIT dosing
Chloridoideae — partial cross-reactivity via Group 1; less than within-Panicoideae cross-reactivity
Is SCIT Right for Your Bahia Grass Allergy?
Answer five questions to assess whether bahia grass SCIT fits your Florida or Gulf Coast allergy profile.
How severe are your grass allergy symptoms during Florida's April–October season?
The Bahia Grass SCIT Protocol
Bahia grass SCIT uses a non-standardized extract (ImmunoCAP g17) dosed in protein nitrogen units (PNU) or weight-per-volume (W/V), typically combined with Bermuda and Johnson grass in a dedicated Panicoideae/Chloridoideae warm-season vial separate from any Pooideae extracts. This separation is critical because bahia requires different optimal dilution than Timothy or ryegrass.
Injections begin at a highly dilute starting concentration and escalate progressively toward the maintenance dose under 30-minute post-injection observation. Because bahia extract is non-standardized, your allergist will titrate the PNU-based dose individually using skin test endpoint results. Some traditional clinic protocols use cluster build-up schedules; Curex uses a conservative once-weekly build-up and does not offer rush or cluster schedules.
Ongoing maintenance injections sustain the immune tolerance achieved during build-up. The April–October Florida pollen season means bahia-sensitized patients receive maintenance injections throughout their peak exposure window — reinforcing tolerance when it matters most. Your allergist will track symptom scores and medication use annually to evaluate sustained clinical benefit.
Patients who complete a full bahia SCIT course typically experience sustained symptom reduction for years after stopping treatment — disease modification rather than simple symptom suppression. Patients with continued high residential or outdoor occupational exposure may elect to continue maintenance indefinitely in consultation with their allergist.
Extract Concentration Ladder
You progress through each vial during build-up. Concentration increases ~10x per step.
What the Research Shows for Bahia Grass SCIT
No published double-blind placebo-controlled SCIT trial has used bahia grass extract as its primary intervention. Efficacy is extrapolated from broader warm-season grass SCIT series and the Panicoideae Group 1 allergen framework — an honest data gap this page acknowledges directly.
- Grass SCIT symptom score reduction (meta-analysis)40%Calderón M et al., 2007, Cochrane Database Syst Rev — broad grass SCIT systematic review
- Florida grass-allergic patients with bahia-specific IgE50%Lo & Bush, 2009, Allergy Asthma Proc — 40–60% range in Florida cohorts
- Pooideae SCIT coverage of bahia challenge0%Florida nasal provocation: zero cross-protection from Timothy against bahia challenge (cited in JTFPP 2011)
There is no published bahia-specific SCIT RCT as of 2024. The Calderón 2007 Cochrane meta-analysis documents robust grass SCIT efficacy broadly, but its primary studies used Pooideae grasses. The more clinically relevant data points for bahia are epidemiological: the 40–60% bahia sensitization rate among Florida grass-allergic patients (Lo & Bush, 2009) and the complete absence of Pooideae cross-protection on nasal challenge confirm that bahia-specific coverage is necessary — even if a dedicated bahia RCT has not yet been published.
Ready to skip the surprise bills?
At-home allergy shots (SCIT) are designed by board-certified allergists. See the listed SCIT plan rate in our pricing record and request a quote for eligibility, initiation and total care costs.
- MD-ledBoard-certified allergists
- QuoteTotal care estimate
- 50K+Patients treated
- HSA/FSAEligible
Bahia Grass SCIT Side Effects
Bahia grass SCIT carries the same local and systemic reaction profile as other inhalant SCIT extracts, managed through the mandatory 30-minute post-injection observation period.
Local reactions
4 documented| Reaction | Rate | Severity |
|---|---|---|
Injection-site swelling Wheal and flare at the injection arm; resolves within hours | Rate 30–50% | Mild |
Injection-site itching Pruritus at injection arm; cold compress provides relief | Rate 25–40% | Mild |
Large local reaction (>25 mm) May trigger dose adjustment; always inform your allergist before next visit | Rate 5–10% | Moderate |
Delayed induration Firm lump persisting 24–48 hours; resolves without treatment | Rate 2–5% | Mild |
Systemic reactions
4 documented| Reaction | Rate | Severity |
|---|---|---|
Nasal/conjunctival flare Brief worsening of baseline allergy symptoms post-injection | Rate 0.5–1% | Mild |
Generalized urticaria Managed with antihistamines; dose reduction at next visit | Rate 0.1–0.3% | Moderate |
Mild bronchospasm More likely in patients with poorly controlled asthma — pre-treatment spirometry recommended | Rate 0.1–0.2% | Moderate |
Systemic anaphylaxis Managed immediately with epinephrine; the 30-minute observation period is the primary safety net | Rate <0.01% | Severe |
No deaths from inhalant SCIT have been reported in the US in the past decade under proper protocols. The non-standardized bahia extract requires careful individualized dose titration — which is exactly why Curex keeps a board-certified allergist overseeing the plan, supervises the first injection from each new vial or concentration live in the Virtual Shot Room, and confirms a prescribed epinephrine auto-injector is on hand, making eligible at-home maintenance possible.
SCIT vs Alternatives for Bahia Grass
Florida and Gulf Coast patients with bahia grass sensitization have four main management options: SCIT with a warm-season grass vial, at-home SLIT drops, avoidance strategies, or daily symptom-control medications.
| Criterion | At-Home SCIT (Curex)Best | SLIT drops/tablets | Avoidance | Medications |
|---|---|---|---|---|
| Effectiveness | Disease-modifying; extrapolated 40%+ reduction (Calderón 2007) | Moderate — no FDA-approved bahia SLIT tablet; custom drops available | Minimal — bahia lines every highway in Florida | Symptom suppression only |
| 5-yr cost | $3,500–$10,000 | $1,500–$4,000 | Low direct cost | $500–$3,000 |
| Duration | 3–5 years | 3–5 years | Ongoing | Indefinite daily use |
| Convenience | At-home self-injection; weekly build-up, then maintenance on a schedule individualized by your allergist | Daily drops at home | High lifestyle burden | Easy — oral/nasal |
| Safety | <0.01% anaphylaxis; Virtual Shot Room–supervised dosing + prescribed epi | Very low systemic risk | Excellent | Generally safe; drowsiness risk |
| Lasting effect | 7–12+ years post-course | Moderate lasting effect | No disease modification | None — symptoms return off medication |
At-Home SCIT (Curex)Best
SLIT drops/tablets
Avoidance
Medications
SCIT with a dedicated warm-season vial covering bahia alongside Bermuda is the most robust disease-modifying option for Gulf Coast patients. Curex delivers that SCIT as an at-home allergy shot with pricing confirmed in a current program quote — a warm-season serum that can include bahia alongside Bermuda, compounded under USP <797>, with the first injection from each new vial or concentration supervised live in the Virtual Shot Room, a prescribed epinephrine auto-injector confirmed on hand, and allergist-overseen escalation — convenient coverage for eligible patients through Florida's long allergy season without weekly clinic trips.
What Bahia Grass SCIT Actually Costs
Most major US insurers cover grass SCIT including bahia under standard allergy benefits when prescribed by a board-certified allergist following documented IgE sensitization. Curex's at-home IgE panel can document Pas n 1 sensitization and provide the clinical basis for prior authorization without requiring an initial office visit. Out-of-pocket costs depend on individual deductible and co-insurance structure.
Cost range varies by deductible, co-insurance, and clinic.
Verify these codes with your insurer to confirm coverage.
See the listed Environmental Allergy Shots Plan rate, commercial terms dated 2026-10-12; consultations are included without copay. Confirm availability, eligibility, other included services, testing, any in-person care, insurance responsibility and billing cadence in your written quote before enrolling.
Join the waitlistStop guessing about your bahia grass allergy. Get a plan.
Take Curex’s 3-minute allergy quiz. A board-certified allergist will review your symptoms and recommend the right immunotherapy path for you — shots or drops.
Free quiz · Board-certified allergists · 50,000+ patients treated · HSA/FSA eligible
Bahia Grass SCIT — Frequently Asked
Quick answers to the questions patients ask most before starting treatment.
For years, Florida allergists performed skin prick testing with a standard panel that included melaleuca (tea tree) extract, and a notable subset of patients showed positive reactions. This was interpreted as melaleuca allergy — a tree pollen sensitization. The Stablein et al. (2002) study published in the Journal of Allergy and Clinical Immunology demonstrated that this apparent melaleuca skin reactivity was actually caused by cross-reactive proteins in bahia grass pollen. The patients were bahia-allergic, not melaleuca-allergic. This finding quietly rewrote the Gulf Coast pollen-testing standard: melaleuca should no longer be assumed from skin test alone, and bahia-specific IgE testing (Pas n 1 / ImmunoCAP g17) is needed to confirm the true sensitization. The practical implication: patients who received melaleuca-targeted treatment without bahia coverage may have experienced unnecessary treatment failure.
Timothy grass (Phleum pratense) contains Group 5 allergens (Phl p 5) that are the dominant cross-reactive proteins across the entire Pooideae subfamily. Bahia grass belongs to the Panicoideae subfamily and completely lacks Group 5 allergens. The only cross-reactivity between bahia and Timothy is at the Group 1 level, which amounts to approximately 38% IgE inhibition (Suphioglu et al., 1992, Lancet). Nasal provocation studies in Florida patients confirmed this directly: patients who responded to bahia nasal challenge showed no clinical reaction to Timothy challenge, demonstrating zero functional cross-protection (cited in Joint Task Force Practice Parameter, 2011). Florida and Gulf Coast patients sensitized primarily to Pas n 1 will not benefit from Timothy or Grastek SLIT and require a separate warm-season Panicoideae vial.
Florida has several important grass pollen sources. Bahia grass (Paspalum notatum, Panicoideae) is the dominant roadside, pasture, and median grass across the state — distinguishable by its Y-shaped raceme seedhead visible from highway shoulders. Bermuda grass (Cynodon dactylon, Chloridoideae) is the dominant residential lawn and golf course grass, with the only FDA-standardized warm-season extract. St. Augustine grass (Stenotaphrum secundatum, Panicoideae) is the most common residential turf for shade-tolerant yards. These three grasses co-occur across Florida and can co-sensitize the same patient, but they belong to different subfamilies with different allergen profiles — meaning a comprehensive warm-season SCIT vial covering all three is often the appropriate clinical approach rather than testing for just one species.
Bahia grass pollen season in Florida runs from approximately April through October, with peak counts in May and June. NAB monitoring stations at Tampa and Jacksonville routinely record bahia pollen counts above 200 grains per cubic meter during peak weeks — the Very High threshold that correlates with symptom onset in sensitized patients. The season is longer in South Florida and can be nearly year-round at low levels in Miami-Dade County and the Keys. Mornings on dry, warm, windy days produce the highest pollen releases, typically before 10 a.m. Patients benefit from monitoring local pollen counts and scheduling outdoor activities for afternoons or rain-dampened days during peak weeks.
Yes. Bahia grass SCIT is appropriate for children with confirmed Pas n 1 IgE sensitization and clinically meaningful symptoms. The 30-minute post-injection observation requirement applies to all patients including children. Some traditional clinic protocols use cluster build-up schedules to reduce total visits; Curex uses a conservative once-weekly build-up and does not offer rush or cluster schedules. Pre-treatment evaluation of asthma control is important, as poorly controlled asthma increases systemic reaction risk. Immunotherapy started in childhood may provide more durable long-term tolerance than treatment begun in adulthood, and can help prevent new sensitizations from developing in atopic children.
Most major US insurers cover grass pollen SCIT, including non-standardized warm-season grasses like bahia, under standard allergy treatment benefits when prescribed by a board-certified allergist following documented IgE sensitization. Because bahia extract is non-standardized (no FDA BAU/mL designation), some insurers may require a written clinical justification noting the Florida or Gulf Coast geographic exposure and the patient's demonstrated Pas n 1 sensitization. CPT codes 95115, 95117, and 95165 apply. Prior authorization processes vary by insurer; your allergist's billing team typically handles this. Out-of-pocket costs over a 3–5 year course typically range from $3,500 to $10,000 depending on the plan structure.
A warm-season SCIT vial including bahia will provide cross-reactive coverage for other Panicoideae grasses, particularly Johnson grass (Sorghum halepense), with approximately 70% IgE inhibition between Pas n 1 and Sor h 1. Coverage of Bermuda grass (Chloridoideae) is partial — roughly 60% at Group 1. For patients with documented multi-grass sensitization across both bahia and Bermuda, allergists typically include both Bermuda (in a separate Chloridoideae vial) and a Panicoideae mix (bahia plus Johnson). Cross-coverage of Pooideae grasses (Timothy, Kentucky bluegrass) is minimal from a bahia extract — these require their own vial if the patient is also sensitized to temperate grasses. Your allergist will design the multi-vial regimen based on your component-resolved diagnostic profile.
No FDA-approved SLIT tablet covers bahia grass — Grastek (Timothy) and Oralair (5-grass mix) contain only Pooideae species and will not address Pas n 1 sensitization. Custom sublingual immunotherapy drops can be formulated to include bahia extract alongside other warm-season grasses; however, published head-to-head comparison data between bahia custom SLIT drops and bahia SCIT are limited, so the best route depends on the individual patient. Both SCIT and SLIT are evidence-based and generally safe, and each fits different patients. For Florida patients with a 6-month exposure season who find clinic visits difficult to sustain, Curex's at-home allergy shot delivers SCIT with Virtual Shot Room–supervised dosing and a prescribed epinephrine auto-injector confirmed on hand. A large safety study of self-administered immunotherapy (Schaffer et al., 2015) found that across 23,614 patients giving 2,021,600 injections, the systemic reaction rate was just 0.16% per patient with no fatalities — lower than the 3%–14% typically seen with office-based shots. A board-certified allergist helps weigh the clinical evidence against your lifestyle to determine which modality fits you best.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Questions about Curex itself?
Straight answers about the company, the evidence, what patients report, and what it costs — including the parts that are not flattering.